Zura Bio Limited Class A ZURA
NASDAQ · United States · Health Technology
$4.11-0.03 (-0.72%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.21 | -0.19 | -9.8% | $0 | — | +2.7%$5.63→$5.78 |
| Q1 2026 | 2026-05-07 | -0.22 | -0.17 | -29.4% | — | — | -2.0%$4.89→$4.79 |
| Q4 2025 | 2026-03-19 | -0.49 | -0.15 | -226.7% | — | — | -8.2%$5.99→$5.50 |
| Q3 2025 | 2025-11-13 | -0.21 | -0.18 | -16.7% | — | — | -11.9%$4.63→$4.08 |
| Q2 2025 | 2025-08-14 | -0.17 | -0.18 | +5.6% | — | — | — |
| Q4 2024 | 2025-03-25 | -0.08 | -0.16 | +50.0% | — | — | — |
| Q2 2024 | 2024-08-13 | -0.17 | -0.15 | -13.3% | — | — | — |
| Q3 2023 | 2023-11-13 | -0.18 | -0.23 | +21.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.